“Comparison Of The Efficacy And Safety Of Secukinumab, Ustekinumab And Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis: A Systematic Review”. 2023. Journal of Pharmaceutical Negative Results, January, 485-95. https://doi.org/10.47750/pnr.2023.14.02.62.